Nu-Med Plus, Inc.
Nu-Med Plus, Inc. (NUMD) Stock Overview
Explore Nu-Med Plus, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.3M
P/E Ratio
-23.62
EPS (TTM)
$0.01
ROE
0.23%
NUMD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Nu-Med Plus, Inc. (NUMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 33.20, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.04.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -23.62 and a market capitalization of 1.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.